SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-019889
Filing Date
2019-11-06
Accepted
2019-11-06 11:15:40
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 27099
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 523139
6 image0.jpg GRAPHIC 11774
  Complete submission text file 0001140361-19-019889.txt   737674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20191106.xsd EX-101.SCH 4389
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20191106_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20191106_pre.xml EX-101.PRE 16832
13 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 191195507
SIC: 2834 Pharmaceutical Preparations